misleading statements

Richtech Robotics faces securities lawsuit after Microsoft denied commercial partnership claimed in January press release. Stock surged 30% then fell 20% following the clarification.

Class action lawsuit filed against $INO for allegedly false statements about INO-3107 treatment and CELLECTRA device. Lead plaintiff deadline is April 7, 2026.

Class action lawsuit filed against $UGDX alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta, claiming Phase III results overstated drug benefits.

Class action lawsuit filed against Richtech Robotics for falsely claiming commercial partnership with Microsoft's AI Co-Innovation Labs, triggering sharp stock decline.

Plug Power faces securities fraud lawsuit over allegedly false DOE loan claims. PLUG shareholders have until April 3, 2026 to file in class action.

Varonis faces class action lawsuit over undisclosed business challenges. Stock crashed 48.7% after disappointing guidance. Investors must act by March 9, 2026.

Varonis faces class action for allegedly misrepresenting ARR growth sustainability, triggering 48.7% stock collapse. Lead plaintiff deadline: March 9, 2026.

Pomerantz files class action against Inovio Pharmaceuticals for alleged securities fraud related to false FDA approval statements and concealed manufacturing deficiencies.

Franklin BSP Realty Trust faces class action lawsuit alleging securities fraud after disclosing delayed property sales and excess dividend distributions. Stock plunged 14.2%.

Rosen Law Firm urges $METC investors to join securities class action alleging false statements about mining operations. Lead plaintiff deadline: March 31, 2026.

Law firm files securities lawsuit against $CORT alleging false statements about FDA interactions regarding relacorilant drug approval prospects.

PayPal faces class action lawsuit alleging securities fraud after stock plummets 20% on disappointing earnings, withdrawn guidance, and CEO transition.

Plug Power faces securities fraud class action for allegedly misrepresenting hydrogen facility capabilities and DOE funding prospects. Shareholders have until April 3, 2026 to join suit.

Law Offices of Frank R. Cruz files class actions against $AGHI, $FRMI, $VRNS, $ARDT for materially false statements. Lead plaintiff deadlines March 2-9, 2026.

Rosen Law Firm announces March 16, 2026 deadline for investors to join securities class action against Vistagen Therapeutics ($VTGN) over alleged misleading statements regarding fasedienol drug trial.

Mereo BioPharma faces securities class action for allegedly concealing failed Phase 3 trials for setrusumab. Investors have until April 6, 2026 to act.

Agilon Health faces securities class action over alleged 2025 guidance misstatements. Lead plaintiff deadline is March 2, 2026 for investors with losses.

Law firm sues Plug Power for allegedly misrepresenting DOE loan prospects and hydrogen facility viability, claiming investor harm through false statements.

Class action filed against $FRMI alleging materially false statements about Project Matador tenant demand and overstated financial prospects since October 2025 IPO.

Class action lawsuit filed against $UGXY alleging securities fraud related to setrusumab clinical trial data. Investors from August 2023 to December 2025 eligible.